China Resources Pharmaceutical Group Ltd. has announced the formation of a new joint venture fund, the China Resources Pharmaceutical (Chengdu) Innovation Investment Fund Partnership (Limited Partnership), with several parties including Chengdu Runyao Industry Investment Partnership and other independent third parties. The fund is set to have a proposed size of RMB1 billion and a term of seven years. China Resources Pharmaceutical Group Ltd. will have a capital commitment of approximately RMB245 million, representing 24.5% of the total fund. The partnership aims to foster innovation and investment within the pharmaceutical sector.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief on July 17, 2025, and is solely responsible for the information contained therein.